|
業務類別
|
Biotechnology |
|
業務概覽
|
Jyong Biotech Ltd is a science-driven biotechnology company based in Taiwan and is committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia (primarily Taiwan and mainland China). It has been dedicated to the research and development of new drugs with high safety and efficacy. It has been developing a series of drug candidates, including one core drug candidate at NDA stage, one clinical-stage key drug candidate and other preclinical-stage drug candidates. |
| 公司地址
| Xintai 5th Road, 23F-3, No. 95, Section 1, Xizhi, New Taipei, TWN, 221 |
| 電話號碼
| +886 227325205 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.healtheverbiotech.com |
| 員工數量
| 32 |
| Mr. Alfred Chung-Chieh Ying |
Chief Financial Officer |
-- |
11/03/2025 |
| Ms. Fu-Feng Kuo |
Chairwoman of the Board and Chief Executive Officer |
-- |
11/03/2025 |
| Dr. Fenglin Hsu |
Director and Chief Technology Officer |
-- |
11/03/2025 |
| Dr. Wanwen Su |
Chief Science Officer |
-- |
11/03/2025 |
|
|
| Ms. Fu-Feng Kuo |
Chairwoman of the Board and Chief Executive Officer |
11/03/2025 |
| Dr. Fenglin Hsu |
Director and Chief Technology Officer |
11/03/2025 |
| Mr. Hung-Shu Fan |
Independent Director |
11/03/2025 |
| Mr. Ming Tsan Hsu |
Independent Director |
11/03/2025 |
| Mr. Pang-Chief Chi |
Independent Director |
11/03/2025 |
|
|
|
|
